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Research into the interaction of fungi with the host has provided significant contributions to mammalian
immunology. Here, I briefly review themost notable of these contributions, starting from the time ofMetchnik-
off, and highlight their impact on our understanding of immunity.Introduction
Much of our current knowledge of the
mechanisms underlying the immune
system have stemmed from explorations
of host-microbe interactions, attributed
mainly to the study of viral and bacterial
pathogens. Yet fungi and their compo-
nents have long been known to influence
immune function, and the contributions
made from the study of fungal infections
are often underappreciated. In light of
the substantial increase in the prevalence
and severity of fungal diseases (due in
large part to immunosuppressive therapy
and AIDS), the study of fungal infections
is receiving greater attention and yielding
new insights into the immune system.
While undoubtedly skewed by my own
interests, for this brief perspective I have
selected a few seminal contributions that
have arisen from the study of fungal-host
interactions and have shaped, or are
shaping, our understanding of immunity.
The Earlier Contributions (1880s–
2000)
Metchnikoff
Metchnikoff’s study of yeast infections in
Daphnia, the transparent water flea, in
the 1880s is one of the earliest contribu-
tions of fungi to our understanding of
modern immunology (Figure 1). Although
his earlier work had already described
foreign body engulfment by host cells,
the large size of the fungal particles
enabled Metchnikoff to account in detail
the recruitment of phagocytic cells to
sites where the pathogen had penetrated
the flea intestinal wall and the ability of
phagocytes to ingest and kill the fungal
pathogen (Metchnikoff, 1884). This work
not only provided strong evidence for
the cellular basis of immunity, but alsopresented early descriptions of the ability
of phagocytes to fuse (i.e., the formation
of giant cells) and the ability of pathogens
to overcome and kill host phagocytes.
Complement
The ability of yeast to inactivate comple-
ment was first observed in the 1900s,
shortly after the existence of these serum
components was recognized. This inacti-
vation of complement by yeast particles
was subsequently shown to be due to
the removal of a heat-resistant compo-
nent, a finding that led to the identifica-
tion of properdin (now known to be a
C3b-binding protein) by Pillemer and
colleagues in the 1950s and the proposal
that there was an alternative pathway of
complement activation (Figure 1) (Pillemer
et al., 1954). This discovery prompted
a great deal of interest, especially as it
represented one of the first examples of
innate or ‘‘natural’’ immunity in mammals,
but was highly controversial, and interest
in thealternative pathwaywaned following
Pillemer’s suicide in 1957. It was not until
the late 1960s that the alternative pathway
of complement activation was rediscov-
ered and became more widely accepted.
Zymosan
For their studies on complement de-
scribed above, Pillemer and colleagues
had developed and utilized zymosan, an
insoluble yeast cell-wall-derived particle
that is now the most widely used fungal
particle in immunology (Pillemer and
Ecker, 1941). In the late 1950s, the admin-
istration of zymosan in vivo was observed
to potently stimulate the immune system,
enhancing phagocytosis and clearance
of foreign bodies (Benacerraf and Se-
bestyen, 1957). This led to an interest in
zymosan as a stimulator of immune func-
tion, and the administration of theseCell Host & Microbefungal particles was subsequently shown
to be able to protect against conditions
such as radiation stress, microbial infec-
tion, and cancer. The chemical composi-
tion of zymosan was described in 1958,
subsequently leading to the identification
of glucan as a major immune-stimulating
component of zymosan (Di Carlo and
Fiore, 1958). Since these early discov-
eries, zymosan has been widely used
to characterize a variety of in vivo and
in vitro immunological phenomena, such
as inflammation, arachidonate metabo-
lism, autoimmunity, phagocytosis, and
cellular migration (Figure 1).
Toll-Like Receptors
The identification of the Toll-like receptors
in the 1990s was one of the most signifi-
cant immunological discoveries of the
last decade, one that originated directly
from the study of fungal infection. Using
amutagenesis approach, the Toll receptor
was identified as a component of a key
signaling pathway involved in inducing
antifungal responses in Drosophila mela-
nogaster. Mutations in Toll and other
members of this pathway rendered flies
highly susceptible to infection with Asper-
gillus fumigatus, and a scanning electron
micrograph showing a fly bristling with
fungal hyphae is one of the iconic images
of this discovery (Figure 1) (Lemaitre
et al., 1996). Similar molecules were
shortly thereafter identified in mammals,
and the study of these pattern recognition
receptors (PRRs) has led directly to an
expansion in our understanding of (and
ability to exploit) themechanisms involved
in innate microbial recognition. Fungal
particles also provided some insightful
early steps in elucidating the function of
these receptors, such as the ability of
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Figure 1. Contributions from Fungi to Our Understanding of Immunity
Selected seminal discoveries from 1884 to 2006 are shown along with representative images, including Metchnikoff (1884); zymosan engulfment by PMN (1941,
image from Kennedy et al., 2007); properdin (1954, trimeric structure); Aspergillus infection in TLR-deficient Drosophila (from Lemaitre et al., 1996); fungal recog-
nition by Dectin-1-expressing fibroblasts (from Brown andGordon, 2001); collaborative signaling between TLR andCLRs (2003); ITAM-likemotifs and Syk kinase
recruitment (2005); the requirement of multiple PRRs for optimal anti-Candida responses (2006); and enhanced Candida infection in the kidneys of CARD9/
mice (from Gross et al., 2006).
Cell Host & Microbe
Forumclasses, the capacity of TLR2 to heterodi-
merize, and discovery of the role of TLR2
in fungal recognition.
The Recent Contributions (2000
Onward)
C-Type Lectins
The search for mammalian receptors
involved in fungal recognition led to the
discovery that members of the C-type
lectin receptor (CLR) superfamily were
also capable of triggering intracellular sig-
naling upon microbial recognition. These
receptors, of which the fungal b-glucan
receptor Dectin-1 is the archetypical
member (Figure 1) (Brown and Gordon,
2001), are able to induce a variety of
cellular responses, such as phagocytosis,
arachidonatemetabolism, and respiratory
burst. Importantly, like the TLRs, signaling
through these receptors can induce the
production of cytokines and chemokines
and direct the development of adaptive10 Cell Host & Microbe 7, January 21, 2010 ªimmunity. Indeed, the ability of these
receptors to induce Th17-type adaptive
responses has been of particular recent
interest. Although largely studied in the
context of antifungal immunity, there is a
growing appreciation that these receptors
are also involved in immunity to other
pathogens and in the control of homeo-
stasis, through the recognition of endoge-
nous ligands.
Intracellular Signaling Pathways
The study of the intracellular signaling
pathways triggered by CLRs following
their interactions with fungi has pro-
vided several significant insights. Perhaps
most surprising was the discovery that
only a single tyrosine residue in the cyto-
plasmic sequence of Dectin-1 was able
to recruit and activate Syk kinase (Fig-
ure 1) (Rogers et al., 2005). Syk is a
key kinase involved in mediating down-
stream signaling from many activation
receptors and was previously thought to2010 Elsevier Inc.interact only with dual tyrosine-based
sequences, the so-called ‘‘immunorecep-
tor tyrosine-based activation motifs’’
(ITAMs). These single tyrosine-based acti-
vation sequencesor ITAM-likemotifs have
subsequently been identified in other
receptors, which are, interestingly, all
members of the C-type lectin superfamily
and appear to serve largely homeostatic
functions.
The identification of caspase recruit-
ment domain 9 (CARD9) as a key down-
stream component of the Syk kinase
pathwaywas another important discovery
that came from studying fungal-host inter-
actions (Figure 1) (Gross et al., 2006), and
polymorphisms in this adaptor molecule
and in Dectin-1 have been found to result
in susceptibility to fungal infections in
humans (Holland and Vinh, 2009). Muta-
tions in this adaptor will likely be associ-
ated with more diseases, as it has since
been shown to have a central role in
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PRRs, such as NOD2 (Hsu et al., 2007)
and RIG-I (Poeck et al., 2010), and has
been implicated in the induction of the
respiratory burst in response to bacteria
(Wu et al., 2009). Other notable but
perhaps less well-appreciated signaling-
related discoveries arising from the study
of interactions with fungi include the
demonstration that Raf-1 kinase, the non-
canonical NF-kB pathway, and NFAT
activation are involved in PRR signaling
and the description of the sequential
recruitment of PRRs to phagosomes
duringmicrobial uptake (Reid et al., 2009).
Interactions between PRRs
The innate recognition of intact microbes
involves multiple host receptors, and
although it is apparent that the interac-
tions between these various receptors
are an important determinant of the result-
ing immune response, our understanding
is still poor. Fungi are recognized by a
large and expanding list of PRRs and are
arguably one of the best models to study
the interactions of different receptors.
The use of these organisms has already
provided valuable evidence that multiple
PRRs are required for optimal antimicro-
bial responses (Figure 1) (Netea et al.,
2006) and has given critical insights into
the effects of interactions between dif-
ferent classes of receptor. Particularly
notable were the discovery of interactions
between the TLRs and CLRs upon stimu-
lationwith fungal particles and thedemon-
stration that they could synergistically
induce as well as repress the production
of certain cytokines, interactions thatinfluence the development of inflamma-
tion and adaptive immunity (Figure 1).
Similar receptor interactions have subse-
quently been observed during the recog-
nition of other pathogens.Conclusions
The study of fungal-host interactions has
provided seminal insights into the under-
lying mechanisms of immunity. As the
study of fungal infections is a rapidly
growing field, there are likely to be many
more discoveries in the future that will
further shape our understanding of mam-
malian immunology. Furthermore, given
the high levels of mortality associated
with systemic fungal diseases, despite
the availability of antifungal drugs, ex-
panding our knowledge in this area (and
also how fungi evade/modulate immunity)
may also provide potential avenues for
adjunctive immunotherapy that could
hopefully be used in treating these devas-
tating diseases.ACKNOWLEDGMENTS
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